Evolution of the management of resectable pancreatic cancer

Susan Tsai, Beth A. Erickson, Kulwinder Dua, Paul S. Ritch, Parag Tolat, Douglas B. Evans

Research output: Contribution to journalReview article

Abstract

In pancreatic cancer, as with many other solid tumors, a commonly held surgical adage - a chance to cut is a chance to cure - has been promulgated throughout the years. Following such reasoning, surgical extirpation of a localized tumor would prevent tumor dissemination and metastatic tumor progression. However, decades of surgical experience have demonstrated that surgical resection alone provides a limited median survival benefit. Despite the optimization of surgical technique and perioperative management over the past three decades, little progress has been made to improve the limited survival of patients with localized pancreatic cancer who receive surgery. In this article, we discuss the rationale for a novel management strategy for patients with resectable pancreatic cancer, which may improve patient selection and the delivery of multimodality therapy.

Original languageEnglish (US)
Pages (from-to)772-778
Number of pages7
JournalJournal of Oncology Practice
Volume12
Issue number9
DOIs
StatePublished - Sep 1 2016
Externally publishedYes

Fingerprint

Pancreatic Neoplasms
Neoplasms
Survival
Patient Selection
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)
  • Health Policy

Cite this

Tsai, S., Erickson, B. A., Dua, K., Ritch, P. S., Tolat, P., & Evans, D. B. (2016). Evolution of the management of resectable pancreatic cancer. Journal of Oncology Practice, 12(9), 772-778. https://doi.org/10.1200/JOP.2016.015818

Evolution of the management of resectable pancreatic cancer. / Tsai, Susan; Erickson, Beth A.; Dua, Kulwinder; Ritch, Paul S.; Tolat, Parag; Evans, Douglas B.

In: Journal of Oncology Practice, Vol. 12, No. 9, 01.09.2016, p. 772-778.

Research output: Contribution to journalReview article

Tsai, S, Erickson, BA, Dua, K, Ritch, PS, Tolat, P & Evans, DB 2016, 'Evolution of the management of resectable pancreatic cancer', Journal of Oncology Practice, vol. 12, no. 9, pp. 772-778. https://doi.org/10.1200/JOP.2016.015818
Tsai S, Erickson BA, Dua K, Ritch PS, Tolat P, Evans DB. Evolution of the management of resectable pancreatic cancer. Journal of Oncology Practice. 2016 Sep 1;12(9):772-778. https://doi.org/10.1200/JOP.2016.015818
Tsai, Susan ; Erickson, Beth A. ; Dua, Kulwinder ; Ritch, Paul S. ; Tolat, Parag ; Evans, Douglas B. / Evolution of the management of resectable pancreatic cancer. In: Journal of Oncology Practice. 2016 ; Vol. 12, No. 9. pp. 772-778.
@article{5cff19ee8eb54b67877263be2b1aeea5,
title = "Evolution of the management of resectable pancreatic cancer",
abstract = "In pancreatic cancer, as with many other solid tumors, a commonly held surgical adage - a chance to cut is a chance to cure - has been promulgated throughout the years. Following such reasoning, surgical extirpation of a localized tumor would prevent tumor dissemination and metastatic tumor progression. However, decades of surgical experience have demonstrated that surgical resection alone provides a limited median survival benefit. Despite the optimization of surgical technique and perioperative management over the past three decades, little progress has been made to improve the limited survival of patients with localized pancreatic cancer who receive surgery. In this article, we discuss the rationale for a novel management strategy for patients with resectable pancreatic cancer, which may improve patient selection and the delivery of multimodality therapy.",
author = "Susan Tsai and Erickson, {Beth A.} and Kulwinder Dua and Ritch, {Paul S.} and Parag Tolat and Evans, {Douglas B.}",
year = "2016",
month = "9",
day = "1",
doi = "10.1200/JOP.2016.015818",
language = "English (US)",
volume = "12",
pages = "772--778",
journal = "Journal of Oncology Practice",
issn = "1554-7477",
publisher = "American Society of Clinical Oncology",
number = "9",

}

TY - JOUR

T1 - Evolution of the management of resectable pancreatic cancer

AU - Tsai, Susan

AU - Erickson, Beth A.

AU - Dua, Kulwinder

AU - Ritch, Paul S.

AU - Tolat, Parag

AU - Evans, Douglas B.

PY - 2016/9/1

Y1 - 2016/9/1

N2 - In pancreatic cancer, as with many other solid tumors, a commonly held surgical adage - a chance to cut is a chance to cure - has been promulgated throughout the years. Following such reasoning, surgical extirpation of a localized tumor would prevent tumor dissemination and metastatic tumor progression. However, decades of surgical experience have demonstrated that surgical resection alone provides a limited median survival benefit. Despite the optimization of surgical technique and perioperative management over the past three decades, little progress has been made to improve the limited survival of patients with localized pancreatic cancer who receive surgery. In this article, we discuss the rationale for a novel management strategy for patients with resectable pancreatic cancer, which may improve patient selection and the delivery of multimodality therapy.

AB - In pancreatic cancer, as with many other solid tumors, a commonly held surgical adage - a chance to cut is a chance to cure - has been promulgated throughout the years. Following such reasoning, surgical extirpation of a localized tumor would prevent tumor dissemination and metastatic tumor progression. However, decades of surgical experience have demonstrated that surgical resection alone provides a limited median survival benefit. Despite the optimization of surgical technique and perioperative management over the past three decades, little progress has been made to improve the limited survival of patients with localized pancreatic cancer who receive surgery. In this article, we discuss the rationale for a novel management strategy for patients with resectable pancreatic cancer, which may improve patient selection and the delivery of multimodality therapy.

UR - http://www.scopus.com/inward/record.url?scp=84987615728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84987615728&partnerID=8YFLogxK

U2 - 10.1200/JOP.2016.015818

DO - 10.1200/JOP.2016.015818

M3 - Review article

C2 - 27621326

AN - SCOPUS:84987615728

VL - 12

SP - 772

EP - 778

JO - Journal of Oncology Practice

JF - Journal of Oncology Practice

SN - 1554-7477

IS - 9

ER -